HomepageEarnings Events Newsdesk 4 hours ago Johnson & Johnson (JNJ) IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG) Johnson & Johnson (NYSE: JNJ) FY 2026 Other Release Morgan Stanley (MS) Bullishness Remains Steady as Geopolitical and Energy Concerns Rise, Morgan Stanley Wealth Management Pulse Survey Finds » « CrowdStrike Holdings, Inc (CRWD) CrowdStrike Extends Its Real-Time Cloud Detection and Response to Google Cloud Newsdesk:
